Cited by 1,821Electroconvulsive Therapy StudiesPoisoning and overdose treatmentsPharmacovigilance and Adverse Drug Reactions

The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.

The Serotonin Syndrome

Boyer, Edward W., Shannon, Michael·2005·New England Journal of Medicine

DOI 10.1056/nejmra041867

Open this paper in CoChat — free account

Abstract

The serotonin syndrome is a potentially life-threatening drug reaction that may result from therapeutic medication use, self-poisoning, or interactions between drugs.

Integrity signals

Registry

Crossref · 10.1056/nejmra041867

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).
Hoyer, D., Clarke, D. E., Fozard, J. R., Hartig, P. R., Martin, G. R., Mylecharane, E. J., Saxena, P. R., & Humphrey, P. P. A. (1994) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06783-3 · Cited by 3,025
The serotonin syndrome
Sternbach, H. A. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.6.705 · Cited by 1,349
The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity
Dunkley, E. J. C., Isbister, G. K., Sibbritt, D. W., Dawson, A. H., & Whyte, I. M. (2003) · QJM · doi:10.1093/qjmed/hcg109 · Cited by 1,032
Neuroleptic malignant syndrome
Levenson, J. L. (1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.10.1137 · Cited by 984
2002 annual report of the American association of poison control centers toxic exposure surveillance system
Watson, W. A., Litovitz, T. L., Rodgers, G. C., Klein‐Schwartz, W., Youniss, J., Rose, S. R., Borys, D. J., & May, M. E. (2003) · The American Journal of Emergency Medicine · doi:10.1016/s0735-6757(03)00088-3 · Cited by 481
Interactions Between Herbal Medicines and Prescribed Drugs
Izzo, A., & Ernst, E. (2012) · Drugs · doi:10.2165/00003495-200161150-00002 · Cited by 464
Relative Toxicity of Selective Serotonin Reuptake Inhibitors (SSRIs) in Overdose
Isbister, G. K., Bowe, S. J., Dawson, A. H., & Whyte, I. M. (2004) · Journal of Toxicology Clinical Toxicology · doi:10.1081/clt-120037428 · Cited by 432
The Libby Zion Case
Asch, D. A., & Parker, R. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198803243181209 · Cited by 396
Effects of Exposure to Selective Serotonin Reuptake Inhibitors During Pregnancy on Serotonergic Symptoms in Newborns and Cord Blood Monoamine and Prolactin Concentrations
Laine, K., Heikkinen, T., Ekblad, U., & Kero, P. O. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.7.720 · Cited by 329
Recreational Ecstasy/MDMA, the serotonin syndrome, and serotonergic neurotoxicity
Parrott, A. C. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00711-0 · Cited by 325

Show all 49 references

Research works printed but not linked: 8

Sampson E, 1999, Br J Gen Pract, 49, 867
Mackay FJ, 1999, Br J Gen Pract, 49, 871
Hoyer D, 1994, Pharmacol Rev, 46, 157
Saper CB. Brain stem modulation of sensation, movement, and consciousness. In: Kandel ER, Schwartz JH, Jessell TM, eds. Principles of neural science. 4th ed. New York: McGraw-Hill, 2000:896.
Kline SS, 1989, Clin Pharm, 8, 510
Whyte I, 2002, J Toxicol Clin Toxicol, 40, 668
Boddy R, 2004, J Toxicol Clin Toxicol, 42, 725
Olsen D, 2004, J Toxicol Clin Toxicol, 42, 744

Sorted by citations

Items 101–200 of 1,000

In Vitro , In Vivo , and Clinical Studies of Tedizolid To Assess the Potential for Peripheral or Central Monoamine Oxidase Interactions
Flanagan, S., Bartizal, K. F., Minassian, S. L., Fang, E., & Prokocimer, P. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00431-13 · Cited by 108
Fatalities Temporally Associated with the Ingestion of Ibogaine
Alper, K., Stajić, M., & Gill, J. R. (2012) · Journal of Forensic Sciences · doi:10.1111/j.1556-4029.2011.02008.x · Cited by 114
Rhabdomyolysis After Ingestion of “Foxy,” a Hallucinogenic Tryptamine Derivative
Alatrash, G., Majhail, N. S., & Pile, J. C. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.4.550 · Cited by 106
Opioid‐induced inhibition of the human 5‐HT and noradrenaline transportersin vitro: link to clinical reports of serotonin syndrome
Rickli, A., Liakoni, E., Hoener, M. C., & Liechti, M. E. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14105 · Cited by 105
Dantrolene in the treatment of MDMA-related hyperpyrexia: a systematic review
Grunau, B. E., Wiens, M. O., & Brubacher, J. R. (2010) · Canadian Journal of Emergency Medicine · doi:10.1017/s1481803500012598 · Cited by 104
Neurobiology of resilience
Feder, A., Charney, D. S., & Collins, K. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511994791.003 · Cited by 105
Significance of an Electrochemical Sensor and Nanocomposites: Toward the Electrocatalytic Detection of Neurotransmitters and Their Importance within the Physiological System
Kaur, H., Siwal, S. S., Saini, R. V., Singh, N., & Thakur, V. K. (2022) · ACS Nanoscience Au · doi:10.1021/acsnanoscienceau.2c00039 · Cited by 104
Treatment Considerations for Patients With Neuropathic Pain and Other Medical Comorbidities
Haanpää, M. L., Gourlay, G. K., Kent, J. L., Miaskowski, C. A., Raja, S. N., Schmader, K. E., & Wells, C. D. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2009.0645 · Cited by 106
Plasma tryptophan and tyrosine levels are independent risk factors for delirium in critically ill patients
Pandharipande, P. P., Morandi, A., Adams, J. R., Girard, T. D., Thompson, J. L., Shintani, A., & Ely, E. W. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1573-6 · Cited by 103
Relevant Issues in the Monitoring and the Toxicology of Antidepressants
Wille, S. M. R., Cooreman, S., Neels, H. M., & Lambert, W. E. (2008) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360701713112 · Cited by 103
Conundrums in neurology: diagnosing serotonin syndrome – a meta-analysis of cases
Werneke, U., Jamshidi, F., Taylor, D. M., & Ott, M. (2016) · BMC Neurology · doi:10.1186/s12883-016-0616-1 · Cited by 102
Clinically Significant Psychotropic Drug-Drug Interactions in the Primary Care Setting
English, B. A., Dortch, M. J., Ereshefsky, L., & Jhee, S. S. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0284-9 · Cited by 101
Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence
Sartorius, N., Baghai, T. C., Baldwin, D. S., Barrett, B. M., Brand, U., Fleischhacker, W., Goodwin, G. M., Grunze, H., Knapp, M. R. J., Leonard, B. E., et al. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008255 · Cited by 103
The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell mice
Cui, S., Lim, K.-C., Shi, L., Lee, M. P., Jearawiriyapaisarn, N., Myers, G., Campbell, A., Harro, D., Iwase, S., Trievel, R. C., et al. (2015) · Blood · doi:10.1182/blood-2015-02-626259 · Cited by 98
Hydroxocobalamin for the Treatment of Vasoplegia: A Review of Current Literature and Considerations for Use
Shapeton, A. D., Mahmood, F. U., & Ortoleva, J. P. (2018) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2018.08.017 · Cited by 95
Postoperative Analgesia in Elderly Patients
Falzone, E., Hoffmann, C., & Keïta, H. (2013) · Drugs & Aging · doi:10.1007/s40266-012-0047-7 · Cited by 94
Selective serotonin reuptake inhibitor poisoning: An evidence-based consensus guideline for out-of-hospital management
Nelson, L. S., Erdman, A. R., Booze, L. L., Cobaugh, D. J., Chyka, P. A., Woolf, A. D., Scharman, E. J., Wax, P. M., Manoguerra, A. S., Christianson, G., et al. (2007) · Clinical Toxicology · doi:10.1080/15563650701285289 · Cited by 92
Heatwaves and their impact on people with alcohol, drug and mental health conditions: a discussion paper on clinical practice considerations: Heatwaves impact mental health conditions
Cusack, L., de Crespigny, C., & Athanasos, P. (2011) · Journal of Advanced Nursing · doi:10.1111/j.1365-2648.2010.05551.x · Cited by 91
Central Serotonergic Neurons Activate and Recruit Thermogenic Brown and Beige Fat and Regulate Glucose and Lipid Homeostasis
McGlashon, J., Gorecki, M. C., Kozlowski, A. E., Thirnbeck, C. K., Markan, K. R., Leslie, K. L., Kotas, M. E., Potthoff, M. J., Richerson, G. B., & Gillum, M. P. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.008 · Cited by 95
Tryptophan Metabolism in Allergic Disorders
Gostner, J. M., Becker, K., Kofler, H., Strasser, B., & Fuchs, D. (2016) · International Archives of Allergy and Immunology · doi:10.1159/000445500 · Cited by 92
Association of Coprescription of Triptan Antimigraine Drugs and Selective Serotonin Reuptake Inhibitor or Selective Norepinephrine Reuptake Inhibitor Antidepressants With Serotonin Syndrome
Orlova, Y. Y., Rizzoli, P. B., & Loder, E. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2017.5144 · Cited by 91
Acute and subacute drug-induced movement disorders
Burkhard, P. R. (2013) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(13)70027-0 · Cited by 90
Demystifying serotonin syndrome (or serotonin toxicity).
Foong-Reichert, A.-L., Grindrod, K., Patel, T., & Kellar, J. (2018) · Europe PMC (PubMed Central) · Cited by 90
Safety and Side Effects of Ayahuasca in Humans—An Overview Focusing on Developmental Toxicology
SANTOS, R. G. D. (2013) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2013.763564 · Cited by 94
Antidepressant use in the elderly: the role of pharmacodynamics and pharmacokinetics in drug safety
Sultana, J., Spina, E., & Trifirò, G. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.1021684 · Cited by 86
Avoiding Serotonin Syndrome: The Nature of the Interaction Between Tramadol and Selective Serotonin Reuptake Inhibitors
Nelson, E. M., & Philbrick, A. M. (2012) · Annals of Pharmacotherapy · doi:10.1345/aph.1q748 · Cited by 86
Serotonin syndrome—A focused review
Mikkelsen, N., Damkier, P., & Pedersen, S. A. (2023) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13912 · Cited by 100
Overview of Serotonin Syndrome
Iqbal, M. M., Basil, M., Kaplan, J., & Iqbal, M. T. (2012) · Annals of Clinical Psychiatry · doi:10.1177/104012371202400410 · Cited by 86
Pyrexia: aetiology in the ICU
Niven, D. J., & Laupland, K. B. (2016) · Critical Care · doi:10.1186/s13054-016-1406-2 · Cited by 86
Modeling environmental risk factors of autism in mice induces IBD-related gut microbial dysbiosis and hyperserotonemia
Lim, J. S., Lim, M. Y., Choi, Y., & Ko, G. (2017) · Molecular Brain · doi:10.1186/s13041-017-0292-0 · Cited by 89
Dextromethorphan poisoning: An evidence-based consensus guideline for out-of-hospital management
Chyka, P. A., Erdman, A. R., Manoguerra, A. S., Christianson, G., Booze, L. L., Nelson, L. S., Woolf, A. D., Cobaugh, D. J., Caravati, E. M., Scharman, E. J., et al. (2007) · Clinical Toxicology · doi:10.1080/15563650701606443 · Cited by 85
Fibromyalgia: A Clinical Update
Hawkins, R. A. (2013) · Journal of Osteopathic Medicine · doi:10.7556/jaoa.2013.034 · Cited by 85
Extreme enhancement or depletion of serotonin transporter function and serotonin availability in autism spectrum disorder
Garbarino, V. R., Gilman, T. L., Daws, L. C., & Gould, G. G. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.07.010 · Cited by 85
Phase 1/2 study of epacadostat in combination with ipilimumab in patients with unresectable or metastatic melanoma
Gibney, G. T., Hamid, O., Lutzky, J., Olszanski, A. J., Mitchell, T. C., Gajewski, T. F., Chmielowski, B., Hanks, B. A., Zhao, Y., Newton, R. C., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0562-8 · Cited by 84
Behavioral effects of citalopram, tramadol, and binary mixture in zebrafish (Danio rerio) larvae
Bachour, R.-L., Golovko, O., Kellner, M., & Pohl, J. (2019) · Chemosphere · doi:10.1016/j.chemosphere.2019.124587 · Cited by 93
Augmentation with Atypical Antipsychotics for Depression: A Review of Evidence‐Based Support from the Medical Literature
Wright, B. M., Eiland, E. H., & Lorenz, R. A. (2013) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1204 · Cited by 88
Pharmacokinetic, Ambulatory, and Hyperthermic Effects of 3,4-Methylenedioxy-N-Methylcathinone (Methylone) in Rats
Štefková, K., Žídková, M., Horsley, R. R., Pinterová, N., Šíchová, K., Uttl, L., Balı́ková, M., Danda, H., Kuchař, M., & Páleníček, T. (2017) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2017.00232 · Cited by 82
Medical Attributes of St. John's Wort (Hypericum perforatum)
Klemow, K. M., Bartlow, A. W., Crawford, J., Kocher, N. J., Shah, J. N., & Ritsick, M. (2011) · Oxidative stress and disease · doi:10.1201/b10787-12 · Cited by 82
The serotonergic system in motor and non-motor manifestations of Parkinson’s disease
Huot, P., & Fox, S. (2013) · Experimental Brain Research · doi:10.1007/s00221-013-3621-2 · Cited by 83
Serotonin Syndrome in the Intensive Care Unit: Clinical Presentations and Precipitating Medications
Pedavally, S., Fugate, J. E., & Rabinstein, A. A. (2013) · Neurocritical Care · doi:10.1007/s12028-013-9914-2 · Cited by 80
Risk of Serotonin Syndrome with Concomitant Administration of Linezolid and Serotonin Agonists
Huang, V., & Gortney, J. S. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.12.1784 · Cited by 80
Perspectives on experimental models of serotonin syndrome in zebrafish
Stewart, A., Cachat, J., Gaikwad, S., Robinson, K. S. L., Gebhardt, M. J., & Kalueff, A. V. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.02.018 · Cited by 84
Pharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines
Taylor, R. W., Marwood, L., Oprea, E., DeAngel, V., Mather, S., Valentini, B., Zahn, R., Young, A. H., & Cleare, A. J. (2020) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaa033 · Cited by 76
Use of psychopharmacological agents for functional gastrointestinal disorders.
Clouse, R. E., & Lustman, P. J. (2005) · Gut · doi:10.1136/gut.2004.048884 · Cited by 76
Septic encephalopathy: does inflammation drive the brain crazy?
Dal‐Pizzol, F., Tomasi, C. D., & Ritter, C. (2014) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2013-1233 · Cited by 81
Qualitative Review of Serotonin Syndrome, Ecstasy (MDMA) and the use of Other Serotonergic Substances: Hierarchy of Risk
Silins, E., Copeland, J., & Dillon, P. (2007) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670701449237 · Cited by 77
Monoamine oxidases in development
Wang, C. C., Billett, E. E., Borchert, A., Kühn, H., & Ufer, C. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1065-7 · Cited by 82
Depression in cancer patients
Dauchy, S., Dolbeault, S., & Reich, M. (2013) · European Journal of Cancer Supplements · doi:10.1016/j.ejcsup.2013.07.006 · Cited by 80
Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities
Rosenbaum, D., Weissman, C., Anderson, T., Petranker, R., Dinh-Williams, L.-A., Hui, K., & Hapke, E. (2020) · Journal of Psychopharmacology · doi:10.1177/0269881120908004 · Cited by 76
Antidepressants: Clinically Relevant Drug Interactions to Be Considered
Schellander, R., & Donnerer, J. (2010) · Pharmacology · doi:10.1159/000319744 · Cited by 76
Bioethics and the Brain
Glannon, W. (2006) · DigitalGeorgetown (Georgetown University Library) · doi:10.1093/acprof:oso/9780195307788.001.0001 · Cited by 75
Dextromethorphan-induced serotonin syndrome
Schwartz, A. R., Pizon, A. F., & Brooks, D. E. (2008) · Clinical Toxicology · doi:10.1080/15563650701668625 · Cited by 75
Serotonin Syndrome
Park, S. H., Wackernah, R. C., & Stimmel, G. L. (2013) · Journal of Pharmacy Practice · doi:10.1177/0897190013504957 · Cited by 75
The Role of Methylene Blue in Serotonin Syndrome: A Systematic Review
Ng, B., & Cameron, A. J. D. (2010) · Psychosomatics · doi:10.1016/s0033-3182(10)70685-x · Cited by 74
Serotonin syndrome: a complex but easily avoidable condition
Dvir, Y., & Smallwood, P. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.09.007 · Cited by 74
Delirium in geriatric patients
Iglseder, B., Frühwald, T., & Jagsch, C. (2022) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-021-00904-z · Cited by 73
Pharmacotherapy of fibromyalgia
Mease, P. J., Dundon, K. M. W., & Sarzi‐Puttini, P. (2011) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2011.01.015 · Cited by 75
Postoperative Delirium: Risk Factors, Prevention, and Treatment
Trabold, B., & Metterlein, T. (2014) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2014.03.017 · Cited by 72
Drugs related to monoamine oxidase activity
Fišar, Z. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.02.012 · Cited by 73
Aquatic blues: Modeling depression and antidepressant action in zebrafish
Nguyen, M., Stewart, A., & Kalueff, A. V. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.03.003 · Cited by 72
Review: Pharmacogenetic aspects of the effect of cytochrome P450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects
Pilgrim, J. L., Gerostamoulos, D., & Drummer, O. H. (2010) · Forensic Science Medicine and Pathology · doi:10.1007/s12024-010-9188-3 · Cited by 71
Stiff Person Syndrome
Ciccotto, G., Blaya, M. T., & Kelley, R. E. (2012) · Neurologic Clinics · doi:10.1016/j.ncl.2012.09.005 · Cited by 70
Receptor mediation of exaggerated responses to serotonin-enhancing drugs in serotonin transporter (SERT)-deficient mice
FOX, M., JENSEN, C., GALLAGHER, P., & MURPHY, D. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.07.009 · Cited by 70
Serotonin Syndrome
Abadie, D., Rousseau, V., Logerot, S., Cottin, J., Montastruc, J., & Montastruc, F. (2015) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000344 · Cited by 70
Clinical review: Agitation and delirium in the critically ill – significance and management
Chevrolet, J.-C., & Jolliet, P. (2007) · Critical Care · doi:10.1186/cc5787 · Cited by 70
Neuropsychiatric complications of commonly used palliative care drugs
Jackson, N., Doherty, J., & Coulter, S. (2008) · Postgraduate Medical Journal · doi:10.1136/pgmj.2007.062117 · Cited by 69
Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement
Dodd, S., Mitchell, P. B., Bauer, M., Yatham, L. N., Young, A. H., Kennedy, S. H., Williams, L. J., Suppes, T. M., López‐Jaramillo, C., Trivedi, M. H., et al. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1379609 · Cited by 66
Linezolid and Serotonin Syndrome
Quinn, D. K., & Stern, T. A. (2009) · The Primary Care Companion to The Journal of Clinical Psychiatry · doi:10.4088/pcc.09r00853 · Cited by 68
A symptom-based approach to pharmacologic management of fibromyalgia
Boomershine, C. S., & Crofford, L. J. (2009) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2009.25 · Cited by 67
Recognition and treatment of serotonin syndrome.
Frank, C. (2008) · Europe PMC (PubMed Central) · Cited by 67
Central neuromodulators for treating functional GI disorders: a primer
Sobin, H. W., Heinrich, T. W., & Drossman, D. A. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.57 · Cited by 64
Lorcaserin (Belviq): A Selective Serotonin 5-HT2C Agonist In the Treatment of Obesity.
Gustafson, A., King, C. T., & Rey, J. A. (2013) · Europe PMC (PubMed Central) · Cited by 66
Potential Medical and Surgical Complications of Serotonergic Antidepressant Medications
Looper, K. J. (2007) · Psychosomatics · doi:10.1176/appi.psy.48.1.1 · Cited by 66
The serotonin toxidrome: shortfalls of current diagnostic criteria for related syndromes
Chiew, A. L., & Buckley, N. A. (2021) · Clinical Toxicology · doi:10.1080/15563650.2021.1993242 · Cited by 65
Effects of MDMA on body temperature in humans
Liechti, M. E. (2014) · Temperature · doi:10.4161/23328940.2014.955433 · Cited by 69
Serotonin Syndrome Associated With MDPV Use: A Case Report
Mugele, J., Nañagas, K., & Tormoehlen, L. M. (2012) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2011.11.033 · Cited by 65
Therapeutic challenges posed by critical drug–drug interactions in cystic fibrosis
Jordan, C. L., Noah, T. L., & Henry, M. M. (2016) · Pediatric Pulmonology · doi:10.1002/ppul.23505 · Cited by 65
Tolerability of Selective Serotonin Reuptake Inhibitors
Draper, B., & Berman, K. (2008) · Drugs & Aging · doi:10.2165/00002512-200825060-00004 · Cited by 64
Relationship between chronic lead toxicity and plasma neurotransmitters in autistic patients from Saudi Arabia
El-Ansary, A. K., Bacha, A. B., & Ayahdi, L. Y. A. (2011) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2011.06.982 · Cited by 64
Simultaneous determination of citalopram and selegiline using an efficient electrochemical sensor based on ZIF-8 decorated with RGO and g-C3N4 in real samples
Karimi-Harandi, M.-H., Shabani‐Nooshabadi, M., & Darabi, R. (2022) · Analytica Chimica Acta · doi:10.1016/j.aca.2022.339662 · Cited by 64
Psychopharmacological Enhancement
Glannon, W. (2008) · Neuroethics · doi:10.1007/s12152-008-9005-9 · Cited by 66
Intubation of Profoundly Agitated Patients Treated with Prehospital Ketamine
Olives, T. D., Nystrom, P. C., Cole, J. B., Dodd, K. W., & Ho, J. D. (2016) · Prehospital and Disaster Medicine · doi:10.1017/s1049023x16000819 · Cited by 63
New Serotonin-Norepinephrine Reuptake Inhibitors and Their Anesthetic and Analgesic Considerations
Fanelli, D., Weller, G. E. R., & Liu, H. (2021) · Neurology International · doi:10.3390/neurolint13040049 · Cited by 62
Beyond Tricyclics
Drossman, D. A. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.341 · Cited by 62
Serotonin syndrome caused by interaction between citalopram and fentanyl
Ailawadhi, S., Sung, K.-W., Carlson, L. A., & Baer, M. R. (2007) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2007.00813.x · Cited by 62
Acute effects of amitriptyline on adult zebrafish: Potential relevance to antidepressant drug screening and modeling human toxidromes
Demin, K. A., Kolesnikova, T. O., Khatsko, S. L., Мешалкина, Д. А., Efimova, E. V., Morzherin, Y. Y., & Kalueff, A. V. (2017) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2017.04.002 · Cited by 66
Ibogaine as a treatment for substance misuse: Potential benefits and practical dangers
Corkery, J. (2018) · Progress in brain research · doi:10.1016/bs.pbr.2018.08.005 · Cited by 67
Antidepressants and the adolescent brain
Cousins, L., & Goodyer, I. M. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115573542 · Cited by 61
Refractory shock and asystole related to tramadol overdose
Daubin, C., Quentin, C., Goullé, J., Guillotin, D., Lehoux, P., Lepage, O., & Charbonneau, P. (2007) · Clinical Toxicology · doi:10.1080/15563650701438847 · Cited by 61
Diagnosis and treatment of drug-induced hyperthermia
Musselman, M. E., & Saely, S. (2012) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp110543 · Cited by 61
Complexities in the pharmacologic management of osteoarthritis pain
McCarberg, B. H., & Tenzer, P. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.785391 · Cited by 61
Neuroleptic malignant syndrome and serotonin syndrome
Tormoehlen, L. M., & Rusyniak, D. E. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64074-1.00039-2 · Cited by 61
Indolealkylamines: Biotransformations and Potential Drug–Drug Interactions
Yu, A. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9028-5 · Cited by 60
In vivo Hippocampal Serotonin Dynamics in Male and Female Mice: Determining Effects of Acute Escitalopram Using Fast Scan Cyclic Voltammetry
Saylor, R. A., Hersey, M., West, A. M., Buchanan, A. M., Berger, S. N., Nijhout, H. F., Reed, M. C., Best, J. A., & Hashemi, P. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00362 · Cited by 56
A systematic review of the serotonergic effects of mirtazapine in humans: implications for its dual action status
Gillman, P. K. (2005) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.750 · Cited by 60
New Antibiotics for Staphylococcus aureus Infection: An Update from the World Association of Infectious Diseases and Immunological Disorders (WAidid) and the Italian Society of Anti-Infective Therapy (SITA)
Esposito, S., Blasi, F., Curtis, N. C., Kaplan, S. L., Lazzarotto, T., Meschiari, M., Mussini, C., Peghin, M., Rodrigo, C., Vena, A., et al. (2023) · Antibiotics · doi:10.3390/antibiotics12040742 · Cited by 58
Recurrent Seizures and Serotonin Syndrome Following “2C-I” Ingestion
Bosak, A. R., LoVecchio, F., & Levine, M. (2013) · Journal of Medical Toxicology · doi:10.1007/s13181-013-0287-x · Cited by 58
Psychopharmacological Treatment in Older People: Avoiding Drug Interactions and Polypharmacy
Kratz, T., & Diefenbacher, A. (2019) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2019.0508 · Cited by 58
Major Depression
Bentley, S. M., Pagalilauan, G. L., & Simpson, S. A. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.06.013 · Cited by 66
Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice
Hauser, R. A., Meyer, J. M., Factor, S. A., Comella, C., Tanner, C. M., Xavier, R. M., Caroff, S. N., & Lundt, L. (2020) · CNS Spectrums · doi:10.1017/s109285292000200x · Cited by 57

Authors: Boyer, E. W., & Shannon, M.
Affiliations: Boston Children's Hospital (US)
ORCID: Boyer, Edward W.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 2005-03-17
Volume: 352
Issue: 11
Pages: 1112-1120
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejmra041867
OpenAlex: W2123778879
Cited by: 1,821
References: 49
Citations by year: 2026: 47 · 2025: 65 · 2024: 84 · 2023: 53 · 2022: 78 · 2021: 74 · 2020: 92 · 2019: 86 · 2018: 99 · 2017: 96 · 2016: 98 · 2015: 112 · 2014: 121 · 2013: 109 · 2012: 93
FWCI: 11.96
Type: journal article
Language: en
Open access: closed
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Drug Abuse (DA14929, R21DA014929)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
Keywords: serotonin syndrome, adverse drug reactions, drug interactions, self-poisoning, serotonin receptor agonists
MeSH terms: Algorithms, Antidepressive Agents, Diagnostic Errors, Drug Interactions, Humans, Monoamine Oxidase Inhibitors, Selective Serotonin Reuptake Inhibitors, Serotonin Syndrome, Drug Overdose

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Serotonin Syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks